SIRT7 and neoplasm: In these contexts, SIRT7 constrains tumor progression by repressing signaling pathways that drive proliferation, survival, epithelial–mesenchymal transition, and metastasis, acting through distinct mechanisms that converge on major downstream cascades, including the TGF-β and AKT pathways and possibly through other mechanisms that remain unknown.